首页> 外文期刊>Journal of Applied Polymer Science >Halloysite/cellulose derivatives-based bionanocomposites for controlled naproxen delivery
【24h】

Halloysite/cellulose derivatives-based bionanocomposites for controlled naproxen delivery

机译:基于埃洛石/纤维素衍生物的生物纳米复合材料,用于可控的萘普生递送

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Bionanocomposites are biocompatible, biodegradable, low-toxicity materials inorganic/biopolymer-based, carrying drugs for controlled delivery. The development of novel materials aiming to improve drug efficacy and reduce its toxicity is a continuous focus of the pharmaceutical industry. In this work, we report the development of an innovative controlled naproxen delivery system. The bionanocomposites are composed of naproxen-loaded halloysite and ethylcellulose/hydroxypropylmethylcellulose blends produced by the spray drying technique. Chemical modification in the halloysite nanotubes was performed, aiming to improve the ionic interactions with the naproxen. The bionanocomposites drug-load efficiency and interactions were characterized by physicochemical analysis. We also evaluated the naproxen release and its transport mechanism. Results show an efficient drug loading into halloysite, varying from 70 to 90. Moreover, the naproxen release was delayed up to four times (compared with raw naproxen), that is, 48 h from nanotubes by Fickian diffusion, and sustained for 60 h from (bio)nanocomposites. The naproxen release from bionanocomposites occurred by several processes as diffusion, polymer swelling, and erosion. Furthermore, no drug was released at simulated gastric fluid, which may reduce the undesirable gastrointestinal effects. The developed bionanocomposites are potential for clinical applications for controlled drug delivery, as naproxen, a nonsteroidal anti-inflammatory, commonly prescribes chronic disease treatment.
机译:生物纳米复合材料是生物相容性、可生物降解、低毒性材料,基于无机/生物聚合物,携带药物进行控制递送。旨在提高药效和降低其毒性的新材料的开发是制药行业持续关注的焦点。在这项工作中,我们报告了一种创新的受控萘普生给药系统的开发。生物纳米复合材料由萘普生负载的埃洛石和乙基纤维素/羟丙基甲基纤维素混合物组成,通过喷雾干燥技术生产。对埃洛石纳米管进行了化学改性,旨在改善与萘普生的离子相互作用。通过理化分析表征了生物纳米复合材料的载药效率和相互作用。我们还评估了萘普生的释放及其转运机制。结果显示,埃洛石中含有有效的药物,从70%到90%不等。此外,萘普生的释放延迟了四倍(与原始萘普生相比),即通过Fickian扩散从纳米管中释放48小时,从(生物)纳米复合材料中持续60小时。萘普生从生物纳米复合材料中释放出来,通过扩散、聚合物溶胀和侵蚀等几个过程发生。此外,模拟胃液中没有释放任何药物,这可能会减少不良的胃肠道影响。开发的生物纳米复合材料具有控制药物递送的临床应用潜力,因为萘普生是一种非甾体抗炎药,通常用于慢性病治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号